Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
Researchers from The University of Texas MD Anderson Cancer Center presented positive clinical results from two studies today at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
Facebook Comments
https://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.png00aajahttps://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.pngaaja2024-06-01 12:03:222024-06-01 12:03:22Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
